Home › Burkitt Lymphoma › Ohio › Columbus
Pag-aaral pangklinika para sa Burkitt Lymphoma sa Columbus, OH
Isang pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
- Nationwide Children's Hospital, Columbus
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Nagre-recruitPhase 3
- Ohio State University Comprehensive Cancer Center, Columbus
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Nagre-recruitPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Nagre-recruitPhase 2
- Nationwide Children's Hospital, Columbus
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Nagre-recruitPhase 3
- Nationwide Children's Hospital, Columbus
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Nagre-recruitPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
Nagre-recruitPhase 1
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
Study of SGR-1505 in Mature B-Cell Neoplasms
Nagre-recruitPhase 1
- The Ohio State University - The James Cancer Hospital, Columbus
Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod
- Houston, TX21 pag-aaral
- Milwaukee, WI16 pag-aaral
- Philadelphia, PA16 pag-aaral
- New York City, NY14 pag-aaral
- Chicago, IL14 pag-aaral
- Cincinnati, OH12 pag-aaral
- Atlanta, GA12 pag-aaral
- Seattle, WA11 pag-aaral
- Durham, NC10 pag-aaral
- Boston, MA10 pag-aaral
- Los Angeles, CA10 pag-aaral
- Aurora, CO10 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer56 pag-aaral
- Kanser sa Suso39 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Kanser sa Baga37 pag-aaral
- Acute Myeloid Leukemia35 pag-aaral
- Chronic Lymphocytic Leukemia28 pag-aaral
- Metastatic Cancer27 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Colorectal Cancer24 pag-aaral
- Kanser sa Prostate24 pag-aaral
- Multiple Myeloma24 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.